|
|
IMPROVING DISABILITY IN KNEE OSTEOARTHRITIS BY TARGETING NEUROMUSCULAR DEFICITS |
| 5R21AR067560-02 |
PIETROSIMONE, BRIAN |
NIAMS |
2016 |
|
|
ANALYSIS OF D4Z4 HETEROCHROMATIN IN FSHD MYOBLAST MODELS |
| 5R21AR067636-02 |
YOKOMORI, KYOKO |
NIAMS |
2016 |
|
|
CCR7 AND ITS LIGANDS IN OSTEOARTHRITIS |
| 5R21AR067916-02 |
SCANZELLO, CARLA ROSE |
NIAMS |
2016 |
|
|
ALLOSTERIC SMALL MOLECULE INHIBITOR OF NERVE GROWTH FACTOR SIGNALING IN LOW BACK PAIN |
| 5R21AR067935-02 |
CHEN, DI |
NIAMS |
2016 |
|
|
A C. ELEGANS DRUG DISCOVERY PLATFORM FOR DYSFERLIN-BASED MUSCULAR DYSTROPHIES |
| 5R21AR068477-02 |
GUARENTE, LEONARD P |
NIAMS |
2016 |
|
|
METHODOLOGIC REMEDIES FOR THE RISK FACTOR PARADOX IN OSTEOARTHRITIS PROGRESSION |
| 5R21AR068493-02 |
CHOI, HYON K |
NIAMS |
2016 |
|
|
USING THE DMD ZEBRAFISH ANIMAL MODEL FOR IDENTIFYING DRUG COMBINATION THERAPIES AND BIOMARKERS |
| 5R21AR068536-02 |
MAVES, LISA A |
NIAMS |
2016 |
|
|
IMPROVING PATIENT-REPORTED OUTCOME MEASURES FOR ORTHOPAEDIC RESEARCH AND PRACTICE |
| 5U01AR067138-03 |
HUNG, MAN |
NIAMS |
2016 |
|
|
HIP FRACTURE EVALUATION ALTERNATIVES OF TOTAL HIP VS HEMI-ARTHROPLASTY (HEALTH) |
| 5UM1AR063386-05 |
EINHORN, THOMAS A. |
NIAMS |
2016 |
